Literature DB >> 10732793

Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.

J D Lin1, M J Liou, T C Chao, H F Weng, Y S Ho.   

Abstract

From 1977 through 1995, 1,013 thyroid carcinoma patients received treatment and were followed up at Chang Gung Medical Center in Taiwan. To evaluate the prognostic variables of papillary and follicular thyroid carcinomas with limited lymph node metastases, a retrospective review of these patients was performed. Of these patients, 910 had papillary or follicular thyroid carcinoma, and 119 patients were categorized as clinical stage 2 with limited neck lymph node metastases only at the time of diagnosis. The patients were categorized into two groups as no recurrence and local recurrence or distant metastasis at the end of 1997. After the operations, radioactive iodide (131I) treatments were performed in 114 patients and external radiotherapy for neck region or distant metastases in 18 patients. The median follow-up period of these patients was 5.4 years. Clinical variables were coded in our computer for statistical analysis. After the treatments, 93 patients remained disease-free; 10 were in stage 2; 5 in stage 3; and 11 aggravated to stage 4. Of the clinical variables, age, post-operative first 1311 uptake scans, and 1-month post-operative thyroglobulin levels revealed statistically significant differences between the group which improved and the group which did not. During the follow-up period, five patients died; three patients died of thyroid cancer and two died of intercurrent diseases. Patients with papillary thyroid carcinoma revealed a higher percentage of lymph node metastases. Although limited lymph node metastases did not influence survival rate, patients with poor prognostic factors need more aggressive treatment to avoid progression of the cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10732793     DOI: 10.1677/erc.0.0060109

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  13 in total

1.  Nodal metastasis in well-differentiated follicular carcinoma of the thyroid: Its incidence and clinical significance.

Authors:  Mitsuyoshi Hirokawa; Yasuhiro Ito; Seiji Kuma; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Akira Miyauchi
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

2.  Correlation analysis on central lymph node metastasis in 276 patients with cN0 papillary thyroid carcinoma.

Authors:  Wendong Wang; Jialei Gu; Jinbiao Shang; Kejing Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

3.  Retrospective analysis of predictive factors for recurrence after curatively resected papillary thyroid carcinoma.

Authors:  Katsuhiro Tanaka; Hiroshi Sonoo; Mai Hirono; Sumiko Ohkubo; Tsunehisa Nomura; Masahiko Ikeda; Kazukata Nakajima; Junichi Kurebayashi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Mortality-related factors in 1056 radioiodine-treated patients with well-differentiated thyroid cancer in southern Thailand.

Authors:  Tada Yipintsoi; Teerapon Premprabha; Alan Geater; Tanyaluck Thientunyakij; Suchitra Thongmak
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

5.  Clinical implication of cancer adhesion in papillary thyroid carcinoma: clinicopathologic characteristics and prognosis analyzed with degree of extrathyroidal extension.

Authors:  Seung Pil Jung; Minkuk Kim; Jun-Ho Choe; Jee Soo Kim; Seok Jin Nam; Jung-Han Kim
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

6.  Risk factors for lateral cervical lymph node involvement in follicular thyroid carcinoma.

Authors:  Haitham Alfalah; Isaac Cranshaw; Thomas Jany; Laurent Arnalsteen; Emmanuelle Leteurtre; Catherine Cardot; François Pattou; Bruno Carnaille
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

7.  Sentinel lymph node biopsy in thyroid tumors: a pilot study.

Authors:  Sandro J Stoeckli; Madeleine Pfaltz; Hans Steinert; Stephan Schmid
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-03-18       Impact factor: 2.503

8.  Factors related to mortality in patients with papillary and follicular thyroid cancer in long-term follow-up.

Authors:  Thaís Gomes de Melo; Denise Engelbrecht Zantut-Wittmann; Elizabeth Ficher; Lígia Vera Montalli da Assumpção
Journal:  J Endocrinol Invest       Date:  2014-07-19       Impact factor: 4.256

9.  Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension.

Authors:  Megan R Haymart; Simone L Glinberg; Jing Liu; Rebecca S Sippel; Juan C Jaume; Herbert Chen
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-03       Impact factor: 3.478

10.  Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?

Authors:  Ummuhan Abdulrezzak; Ahmet Tutus; Mustafa Kula; Figen Oztürk; Işın Soyuer
Journal:  Mol Imaging Radionucl Ther       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.